Shirakawa S - Search Results

1

Decreased expression of type II protein kinase C in HL-60 variant cells resistant to induction of cell differentiation by phorbol diester.

Nishikawa M, Komada F, Uemura Y, Hidaka H, Shirakawa S. Nishikawa M, et al. Among authors: shirakawa s. Cancer Res. 1990 Feb 1;50(3):621-6. Cancer Res. 1990. PMID: 2297701

2

Expression of three major protein kinase C isozymes in various types of human leukemic cells.

Komada F, Nishikawa M, Uemura Y, Morita K, Hidaka H, Shirakawa S. Komada F, et al. Among authors: shirakawa s. Cancer Res. 1991 Aug 15;51(16):4271-8. Cancer Res. 1991. PMID: 1868447

3

Alteration of intracellular actin levels induced by phorboldiester in human HL-60 leukemia cells susceptible or resistant to differentiation, and the effects of protein kinase inhibitors.

Uemura Y, Nishikawa M, Komada F, Shirakawa S. Uemura Y, et al. Among authors: shirakawa s. Leuk Res. 1989;13(7):545-52. doi: 10.1016/0145-2126(89)90121-5. Leuk Res. 1989. PMID: 2761290

4

The expression and possible roles of protein kinase C in haematopoietic cells.

Nishikawa M, Shirakawa S. Nishikawa M, et al. Among authors: shirakawa s. Leuk Lymphoma. 1992 Oct;8(3):201-11. doi: 10.3109/10428199209054906. Leuk Lymphoma. 1992. PMID: 1337006 Review.

5

A role for protein kinase C in the growth of human erythroid progenitor cells.

Katayama N, Nishikawa M, Shimizu N, Komada F, Sekine T, Minami N, Shirakawa S. Katayama N, et al. Among authors: shirakawa s. Leuk Res. 1992;16(2):145-51. doi: 10.1016/0145-2126(92)90125-q. Leuk Res. 1992. PMID: 1545567

6

Clinical response to busramustine (KM-2210) in chronic lymphocytic leukemia: a pilot evaluation of estrogen receptor in relation to its therapeutic effect.

Nishikawa M, Uemura Y, Komada F, Ohno T, Katayama N, Shirakawa S. Nishikawa M, et al. Among authors: shirakawa s. Jpn J Clin Oncol. 1988 Dec;18(4):327-33. Jpn J Clin Oncol. 1988. PMID: 3204682

7

Possible involvement of direct stimulation of protein kinase C by unsaturated fatty acids in platelet activation.

Nishikawa M, Hidaka H, Shirakawa S. Nishikawa M, et al. Among authors: shirakawa s. Biochem Pharmacol. 1988 Aug 15;37(16):3079-89. doi: 10.1016/0006-2952(88)90304-8. Biochem Pharmacol. 1988. PMID: 3401239

8

1-(5-Isoquinolinesulfonyl)-2-methylpiperazine(H-7), a potent inhibitor of protein kinases, inhibits the differentiation of HL-60 cells induced by phorbol diester.

Nishikawa M, Uemura Y, Hidaka H, Shirakawa S. Nishikawa M, et al. Among authors: shirakawa s. Life Sci. 1986 Sep 22;39(12):1101-7. doi: 10.1016/0024-3205(86)90202-x. Life Sci. 1986. PMID: 3462446

9

Forskolin potentiates G-CSF-induced proliferation of a murine myeloblastic leukemia cell line.

Kobayashi K, Nishikawa M, Omay SB, Toyoda H, Deguchi K, Shirakawa S. Kobayashi K, et al. Among authors: shirakawa s. Leuk Res. 1994 Feb;18(2):111-7. doi: 10.1016/0145-2126(94)90127-9. Leuk Res. 1994. PMID: 7509014

10

A role for calmodulin in the growth of human hematopoietic progenitor cells.

Katayama N, Nishikawa M, Komada F, Minami N, Shirakawa S. Katayama N, et al. Among authors: shirakawa s. Blood. 1990 Apr 1;75(7):1446-54. Blood. 1990. PMID: 1690578 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

532 results

Search Page

Filters